116 related articles for article (PubMed ID: 38380803)
1. Chiral Nanoclusters as Alternative Therapeutic Strategies to Confront the Health Threat from Antibiotic-Resistant Pathogens.
Wang Z; Tian Y; Hao J; Liu Y; Tang J; Xu Z; Liu Y; Tang B; Huang X; Zhu N; Li Z; Hu L; Li L; Wang Y; Jiang G
ACS Nano; 2024 Mar; 18(9):7253-7266. PubMed ID: 38380803
[No Abstract] [Full Text] [Related]
2. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
Yuan YG; Peng QL; Gurunathan S
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272303
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.
de Lacerda Coriolano D; de Souza JB; Bueno EV; Medeiros SMFRDS; Cavalcanti IDL; Cavalcanti IMF
Braz J Microbiol; 2021 Mar; 52(1):267-278. PubMed ID: 33231865
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa.
Nour El Din S; El-Tayeb TA; Abou-Aisha K; El-Azizi M
Int J Nanomedicine; 2016; 11():1749-58. PubMed ID: 27175075
[TBL] [Abstract][Full Text] [Related]
5. L-Cysteine and
Vishnevetskii DV; Averkin DV; Efimov AA; Lizunova AA; Shamova OV; Vladimirova EV; Sukhareva MS; Mekhtiev AR
J Mater Chem B; 2023 Jun; 11(25):5794-5804. PubMed ID: 37254915
[TBL] [Abstract][Full Text] [Related]
6. Silver Nanoparticles and Their Antibacterial Applications.
Bruna T; Maldonado-Bravo F; Jara P; Caro N
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281254
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant
Liao S; Zhang Y; Pan X; Zhu F; Jiang C; Liu Q; Cheng Z; Dai G; Wu G; Wang L; Chen L
Int J Nanomedicine; 2019; 14():1469-1487. PubMed ID: 30880959
[TBL] [Abstract][Full Text] [Related]
8. Porous Polymersomes as Carriers for Silver Nanoparticles and Nanoclusters: Advantages of Compartmentalization for Antimicrobial Usage.
Berking BB; Mallen-Huertas L; Rijpkema SJ; Wilson DA
Biomacromolecules; 2023 Dec; 24(12):5905-5914. PubMed ID: 37949646
[TBL] [Abstract][Full Text] [Related]
9. Bi
Pant BD; Benin BM; Abeydeera N; Kim MH; Huang SD
Biomater Sci; 2022 Mar; 10(6):1523-1531. PubMed ID: 35171156
[TBL] [Abstract][Full Text] [Related]
10. Nanosilver Mitigates Biofilm Formation via FapC Amyloidosis Inhibition.
Huma ZE; Javed I; Zhang Z; Bilal H; Sun Y; Hussain SZ; Davis TP; Otzen DE; Landersdorfer CB; Ding F; Hussain I; Ke PC
Small; 2020 May; 16(21):e1906674. PubMed ID: 31984626
[TBL] [Abstract][Full Text] [Related]
11. Silver Nanoparticle Conjugated Star PCL-
Zhen JB; Kang PW; Zhao MH; Yang KW
Bioconjug Chem; 2020 Jan; 31(1):51-63. PubMed ID: 31830418
[TBL] [Abstract][Full Text] [Related]
12. A novel antimicrobial peptide Scyreptin
Zhang W; An Z; Bai Y; Zhou Y; Chen F; Wang KJ
Biochem Pharmacol; 2023 Dec; 218():115917. PubMed ID: 37952897
[TBL] [Abstract][Full Text] [Related]
13. Ultrasmall silver nanoclusters: Highly efficient antibacterial activity and their mechanisms.
Jin JC; Wu XJ; Xu J; Wang BB; Jiang FL; Liu Y
Biomater Sci; 2017 Jan; 5(2):247-257. PubMed ID: 27921105
[TBL] [Abstract][Full Text] [Related]
14. A novel ruthenium-silver based antimicrobial potentiates aminoglycoside activity against
Donkor GY; Anderson GM; Stadler M; Tawiah PO; Orellano CD; Edwards KA; Dahl J-U
mSphere; 2023 Oct; 8(5):e0019023. PubMed ID: 37646510
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial efficacy of silver nanoparticles against metallo-β-lactamase (blaNDM, blaVIM, blaOXA) producing clinically isolated Pseudomonas aeruginosa.
Qureshi R; Qamar MU; Shafique M; Muzammil S; Rasool MH; Ahmad I; Ejaz H
Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):237-243. PubMed ID: 34275847
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of silver nanoclusters in colloidal scaffold for biolabeling and antimicrobial applications.
Xu J; Ramasamy M; Tang T; Wang Y; Zhao W; Tam KC
J Colloid Interface Sci; 2022 Oct; 623():883-896. PubMed ID: 35636296
[TBL] [Abstract][Full Text] [Related]
17. Sustained broad-spectrum antibacterial effects of nanoliposomes loaded with silver nanoparticles.
Eid KA; Azzazy HM
Nanomedicine (Lond); 2014 Jul; 9(9):1301-10. PubMed ID: 24024570
[TBL] [Abstract][Full Text] [Related]
18. Visible light plasmon excitation of silver nanoparticles against antibiotic-resistant Pseudomonas aeruginosa.
da Silva RTP; Petri MV; Valencia EY; Camargo PHC; de Torresi SIC; Spira B
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101908. PubMed ID: 32634655
[TBL] [Abstract][Full Text] [Related]
19. Delivery of antibacterial silver nanoclusters to
Soundy J; Day D
J Med Microbiol; 2020 Apr; 69(4):640-652. PubMed ID: 32125966
[No Abstract] [Full Text] [Related]
20. In vivo antimicrobial activity of silver nanoparticles produced via a green chemistry synthesis using
Escárcega-González CE; Garza-Cervantes JA; Vázquez-Rodríguez A; Montelongo-Peralta LZ; Treviño-González MT; Díaz Barriga Castro E; Saucedo-Salazar EM; Chávez Morales RM; Regalado Soto DI; Treviño González FM; Carrazco Rosales JL; Cruz RV; Morones-Ramírez JR
Int J Nanomedicine; 2018; 13():2349-2363. PubMed ID: 29713166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
